Abner Herrman & Brock’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $576K | Hold |
10,000
| – | – | 0.05% | 67 |
|
|
2026
Q1 | $606K | Buy |
+10,000
| New | +$583K | 0.07% | 61 |
|
|
2023
Q4 | – | Sell |
-3,520
| Closed | -$204K | – | 97 |
|
|
2023
Q3 | $204K | Hold |
3,520
| – | – | 0.03% | 86 |
|
|
2023
Q2 | $225K | Sell |
3,520
-210,264
| -98% | -$14.1M | 0.03% | 91 |
|
|
2023
Q1 | $14.8M | Sell |
213,784
-5,673
| -3% | -$400K | 2.24% | 22 |
|
|
2022
Q4 | $15.8M | Buy |
219,457
+1,586
| +0.7% | +$120K | 2.43% | 22 |
|
|
2022
Q3 | $15.5M | Buy |
217,871
+1,220
| +0.6% | +$88.5K | 2.84% | 15 |
|
|
2022
Q2 | $16.7M | Buy |
+216,651
| New | +$16.5M | 2.88% | 13 |
|
|
2020
Q4 | – | Sell |
-4,242
| Closed | -$256K | – | 118 |
|
|
2020
Q3 | $256K | Sell |
4,242
-63,383
| -94% | -$3.81M | 0.04% | 95 |
|
|
2020
Q2 | $3.98M | Buy |
67,625
+24
| +0% | +$1.44K | 0.71% | 39 |
|
|
2020
Q1 | $3.77M | Sell |
67,601
-500
| -0.7% | -$30.6K | 0.85% | 35 |
|
|
2019
Q4 | $4.37M | Buy |
+68,101
| New | +$3.9M | 0.65% | 40 |
|
|
2018
Q2 | – | Sell |
-8,735
| Closed | -$553K | – | 132 |
|
|
2018
Q1 | $553K | Sell |
8,735
-200
| -2% | -$12.9K | 0.09% | 82 |
|
|
2017
Q4 | $548K | Buy |
8,935
+638
| +8% | +$39.9K | 0.09% | 82 |
|
|
2017
Q3 | $529K | Buy |
8,297
+1,155
| +16% | +$67.4K | 0.09% | 85 |
|
|
2017
Q2 | $398K | Buy |
+7,142
| New | +$389K | 0.08% | 101 |
|
|
2017
Q1 | – | Sell |
-199,954
| Closed | -$12M | – | 122 |
|
|
2016
Q4 | $12M | Sell |
199,954
-4,313
| -2% | -$236K | 2.53% | 10 |
|
|
2016
Q3 | $11M | Buy |
204,267
+4,961
| +2% | +$319K | 2.5% | 8 |
|
|
2016
Q2 | $15M | Sell |
199,306
-363
| -0.2% | -$25.6K | 3.5% | 2 |
|
|
2016
Q1 | $12.8M | Buy |
199,669
+56,919
| +40% | +$3.59M | 3.21% | 2 |
|
|
2015
Q4 | $9.82M | Sell |
142,750
-600
| -0.4% | -$39.6K | 5.06% | 1 |
|
|
2015
Q3 | $8.68M | Buy |
143,350
+240
| +0.2% | +$15.2K | 4.63% | 3 |
|
|
2015
Q2 | $9.72M | Buy |
143,110
+2,020
| +1% | +$133K | 4.87% | 2 |
|
|
2015
Q1 | $9.1M | Buy |
141,090
+2,760
| +2% | +$173K | 4.63% | 3 |
|
|
2014
Q4 | $8.17M | Sell |
138,330
-51,685
| -27% | -$2.91M | 4.14% | 3 |
|
|
2014
Q3 | $9.72M | Buy |
190,015
+7,990
| +4% | +$399K | 2.86% | 6 |
|
|
2014
Q2 | $8.83M | Buy |
182,025
+4,790
| +3% | +$236K | 2.67% | 7 |
|
|
2014
Q1 | $9.21M | Buy |
177,235
+325
| +0.2% | +$17.3K | 2.95% | 6 |
|
|
2013
Q4 | $9.31M | Buy |
176,910
+71,294
| +68% | +$3.63M | 3.3% | 3 |
|
|
2013
Q3 | $4.89M | Sell |
105,616
-64,785
| -38% | -$2.84M | 3.24% | 2 |
|
|
2013
Q2 | $7.62M | Buy |
+170,401
| New | +$7.4M | 3.23% | 3 |
|
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Abner Herrman & Brock's BMY Position: Q2 2026 in Review
Abner Herrman & Brock held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 10,000 shares worth $576K. The position accounts for 0.05% of the portfolio, ranked #67.
Abner Herrman & Brock first reported a position in BMY in Q2 2013 and has held it in 31 quarters since. The position peaked at $16.7M in Q2 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Abner Herrman & Brock held 10,000 shares of Bristol-Myers Squibb worth $576K as of Q2 2026.
- Abner Herrman & Brock left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of Abner Herrman & Brock's portfolio in Q2 2026, its #67 holding.
- Abner Herrman & Brock first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 31 quarters since.
- Abner Herrman & Brock's Bristol-Myers Squibb position peaked at $16.7M in Q2 2022.
- 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.